Induction of telomerase activity during development of human mast cells from peripheral blood CD34+ cells:: Comparisons with tumor mast-cell lines

被引:25
作者
Chaves-Dias, C
Hundley, TR
Gilfillan, AM
Kirshenbaum, AS
Cunha-Melo, JR
Metcalfe, DD
Beaven, MA
机构
[1] NHLBI, Immunol Lab, NIH, Bethesda, MD 20892 USA
[2] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.4049/jimmunol.166.11.6647
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
To further characterize the development of mast cells from human hemopoietic pluripotent cells we have investigated the expression of telomerase activity in cultured human peripheral blood CD34(+) cells, and CD34(+)/CD117(+)/CD13(+) progenitor mast cells selected therefrom, with the idea that induction of telomerase is associated with clonal expansion of CD34(+)/CD117(+)/CD13(+) cells. A rapid increase in telomerase activity preceded proliferation of both populations of cells in the presence of stern Cell factor and either IL-3 or IL-6. The induction was transient, and telomerase activity declined to basal levels well before the appearance of mature mast cells. Studies with pharmacologic inhibitors suggested that this induction was initially dependent on the p38 mitogen-activated protein kinase and phosphatidylinositol 3 ' -kinase, but once cell replication was underway telomerase activity, but not cell replication, became resistant to the effects of inhibitors. Tumor mast cell lines, in contrast, expressed persistently high telomerase activity throughout the cell cycle, and this expression was unaffected by inhibitors of all known signaling pathways in mast cells even when cell proliferation was blocked for extended periods. These results suggest that the transient induction of telomerase activity in human progenitor mast cells was initially dependent on growth factor-mediated signals, whereas maintenance of high activity in tumor mast cell lines was not dependent on intracellular signals or cell replication.
引用
收藏
页码:6647 / 6656
页数:10
相关论文
共 76 条
[1]  
Albanell J, 1996, CANCER RES, V56, P1503
[2]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[3]   IGE-INDUCED HISTAMINE-RELEASE FROM RAT BASOPHILIC LEUKEMIA-CELL LINES - ISOLATION OF RELEASING AND NON-RELEASING CLONES [J].
BARSUMIAN, EL ;
ISERSKY, C ;
PETRINO, MG ;
SIRAGANIAN, RP .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1981, 11 (04) :317-323
[4]  
BAYER BM, 1980, J BIOL CHEM, V255, P8784
[5]   The activation of p38 and apoptosis by the inhibition of ERK is antagonized by the phosphoinositide S-kinase/Akt pathway [J].
Berra, E ;
Diaz-Meco, MT ;
Moscat, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (17) :10792-10797
[6]   TELOMERASES [J].
BLACKBURN, EH .
ANNUAL REVIEW OF BIOCHEMISTRY, 1992, 61 :113-129
[7]   Extension of life-span by introduction of telomerase into normal human cells [J].
Bodnar, AG ;
Ouellette, M ;
Frolkis, M ;
Holt, SE ;
Chiu, CP ;
Morin, GB ;
Harley, CB ;
Shay, JW ;
Lichtsteiner, S ;
Wright, WE .
SCIENCE, 1998, 279 (5349) :349-352
[8]   Mechanism of telomerase induction during T cell activation [J].
Bodnar, AG ;
Kim, NW ;
Effros, RB ;
Chiu, CP .
EXPERIMENTAL CELL RESEARCH, 1996, 228 (01) :58-64
[9]   THERAPEUTIC POTENTIAL OF PROTEIN-KINASE-C INHIBITORS [J].
BRADSHAW, D ;
HILL, CH ;
NIXON, JS ;
WILKINSON, SE .
AGENTS AND ACTIONS, 1993, 38 (1-2) :135-147
[10]  
BRIZZI MF, 1994, J BIOL CHEM, V269, P31680